These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. A novel de novo mutation of SCN8A (Nav1.6) with enhanced channel activation in a child with epileptic encephalopathy. Estacion M; O'Brien JE; Conravey A; Hammer MF; Waxman SG; Dib-Hajj SD; Meisler MH Neurobiol Dis; 2014 Sep; 69():117-23. PubMed ID: 24874546 [TBL] [Abstract][Full Text] [Related]
16. Role of the hippocampus in Nav1.6 (Scn8a) mediated seizure resistance. Makinson CD; Tanaka BS; Lamar T; Goldin AL; Escayg A Neurobiol Dis; 2014 Aug; 68():16-25. PubMed ID: 24704313 [TBL] [Abstract][Full Text] [Related]
17. De novo gain-of-function and loss-of-function mutations of SCN8A in patients with intellectual disabilities and epilepsy. Blanchard MG; Willemsen MH; Walker JB; Dib-Hajj SD; Waxman SG; Jongmans MC; Kleefstra T; van de Warrenburg BP; Praamstra P; Nicolai J; Yntema HG; Bindels RJ; Meisler MH; Kamsteeg EJ J Med Genet; 2015 May; 52(5):330-7. PubMed ID: 25725044 [TBL] [Abstract][Full Text] [Related]
18. Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome. Lenk GM; Jafar-Nejad P; Hill SF; Huffman LD; Smolen CE; Wagnon JL; Petit H; Yu W; Ziobro J; Bhatia K; Parent J; Giger RJ; Rigo F; Meisler MH Ann Neurol; 2020 Mar; 87(3):339-346. PubMed ID: 31943325 [TBL] [Abstract][Full Text] [Related]
19. Genetic and clinical features of SCN8A developmental and epileptic encephalopathy. Kim HJ; Yang D; Kim SH; Kim B; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC Epilepsy Res; 2019 Dec; 158():106222. PubMed ID: 31675620 [TBL] [Abstract][Full Text] [Related]
20. The voltage-gated sodium channel Scn8a is a genetic modifier of severe myoclonic epilepsy of infancy. Martin MS; Tang B; Papale LA; Yu FH; Catterall WA; Escayg A Hum Mol Genet; 2007 Dec; 16(23):2892-9. PubMed ID: 17881658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]